SAN

99.12

-3.52%↓

EI

265.6

-0.78%↓

SHL.DE

49.36

-1.48%↓

ARGX

525

-3.78%↓

PHIA

22.89

-3.66%↓

SAN

99.12

-3.52%↓

EI

265.6

-0.78%↓

SHL.DE

49.36

-1.48%↓

ARGX

525

-3.78%↓

PHIA

22.89

-3.66%↓

SAN

99.12

-3.52%↓

EI

265.6

-0.78%↓

SHL.DE

49.36

-1.48%↓

ARGX

525

-3.78%↓

PHIA

22.89

-3.66%↓

SAN

99.12

-3.52%↓

EI

265.6

-0.78%↓

SHL.DE

49.36

-1.48%↓

ARGX

525

-3.78%↓

PHIA

22.89

-3.66%↓

SAN

99.12

-3.52%↓

EI

265.6

-0.78%↓

SHL.DE

49.36

-1.48%↓

ARGX

525

-3.78%↓

PHIA

22.89

-3.66%↓

Search

Fresenius SE & Co KGaA

Avatud

SektorTervishoid

38.84 -1.92

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

38.45

Max

39.74

Põhinäitajad

By Trading Economics

Sissetulek

-55M

264M

Müük

264M

5.6B

P/E

Sektori keskmine

48.146

63.778

Kasumimarginaal

4.689

Töötajad

176,486

EBITDA

-33M

724M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+15.32% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. mai 2025

Turustatistika

By TradingEconomics

Turukapital

1.4B

22B

Eelmine avamishind

40.76

Eelmine sulgemishind

38.84

Uudiste sentiment

By Acuity

56%

44%

307 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Fresenius SE & Co KGaA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. veebr 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

5. juuni 2024, 12:18 UTC

Market Talk

Fresenius Helios Guidance Lift Should Drive Consensus Upgrades -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Fresenius SE & Co KGaA Prognoos

Hinnasiht

By TipRanks

15.32% tõus

12 kuu keskmine prognoos

Keskmine 45.4 EUR  15.32%

Kõrge 48 EUR

Madal 42 EUR

Põhineb 12 Wall Streeti analüütiku instrumendi Fresenius SE & Co KGaA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

12 ratings

11

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

39.05 / 39.92Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Weak Bearish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

307 / 386 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.